H-Asn (glcnac-beta-D) -OH

H-Asn (glcnac-beta-D) -OH is an endogenous metabolite present in Urine that can be used for the research of NGLY1-CDDG[1][2].

Product Specifications

CAS Number

[2776-93-4]

UNSPSC

12352005

Hazard Statement

H315, H319, H335

Target

Endogenous Metabolite

Type

Natural Products

Related Pathways

Metabolic Enzyme/Protease

Applications

Metabolism-protein/nucleotide metabolism

Field of Research

Others

Assay Protocol

https://www.medchemexpress.com/h-asn-glcnac-beta-d-oh.html

Purity

98.65

Solubility

H2O : 125 mg/mL (ultrasonic)

Smiles

OC([C@@H](N)CC(N[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)NC(C)=O)=O)=O

Molecular Formula

C12H21N3O8

Molecular Weight

335.31

Precautions

H315, H319, H335

References & Citations

[1]Haijes HA, et al. Aspartylglycosamine is a biomarker for NGLY1-CDDG, a congenital disorder of deglycosylation. Mol Genet Metab. 2019 Aug;127 (4) :368-372. |[2]Lee N, et al. Endogenous toxic metabolites and implications in cancer therapy. Oncogene. 2020 Aug;39 (35) :5709-5720.